Lobbying by Arthritis Society Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
In-house (organization)In effect since Mar 31, 2026Receives government funding
Filed by Patricia Barbato, President and Chief Executive Officer
Lobbyists
Cheryl McClellan · Chief Operating Officer
Kelly Gorman · Senior Director Public Policy & Government Affairs
Sian Bevan · Chief Science Officer
Institutions they may lobby: Canada Foundation for Innovation, Canadian Institutes of Health Research (CIHR), Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC), Employment and Social Development Canada (ESDC), Finance Canada (FIN), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), Prime Minister's Office (PMO), Public Health Agency of Canada (PHAC), Senate of Canada, Statistics Canada (StatCan)
What they're lobbying on (5)Hide details
Discussions with government officials about timely access to care and treatment for people living with arthritis (including pharmacare, addressing wait times, models of care, and pain management).
Excise Tax Act, specifically with respect to the application of sales tax on medical cannabis
Discussions with government officials with respect to policy and regulation of medical cannabis.
Discussions with government about strategies and supports to help improve quality of life for people living with arthritis.
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.
Jill Pilgrim · Director of Policy, Health Care Systems and Legal Affairs, Health Canada (HC)
Discussions with government officials about timely access to care and treatment for people living with arthritis (including pharmacare, addressing wait times, models of care, and pain management).Read more
Ceanray Harris-Read · Assistant to Senator Yussuff, Senate of Canada
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.Read more
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.
Kiara Nazon · Parliamentary Affairs Advisor to Senator Moodie, Senate of Canada
Branavi Raveendran · Special Assistant to Senator Moodie, Senate of Canada
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.Read more
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.
Jocelyne Voisin · Assistant Deputy Minister, Health Canada (HC)
Elizabeth Toller · Director General,Health Care Strategies, Health Canada (HC)
Michael Davies · Director, Health Care System Division, Health Canada (HC)
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.Read more
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.
Laurence Lefebvre · Senior Quebec Advisor, Health Canada (HC)
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.Read more
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.
Elaine Cote · Member's Assistant to MP Julian, Health Canada (HC)
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.Read more
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.Read more
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.Read more
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.
Arif Virani · Minister of Justice and Attorney General, House of Commons
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.Read more
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.
Larry Maguire · Member of Parliament, House of Commons
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.Read more
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.
Francesco Sorbara · Member of Parliment, House of Commons
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.Read more
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.Read more
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.
Leah Taylor Roy · Member of Parliament, House of Commons
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.Read more
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.
Robert Kitchen · Member of Parlilament, House of Commons
Discussion with government official about national pharmacare and timely access to treatment for people living with arthritis including addressing wait times for joint replacement surgery and pain management.Read more
Advocate for increased government funding for research, innovation and data related to arthritis and to support patient oriented research. Government support for health charities.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.